Idelalisib

Results: 8



#Item
1Clinical medicine / Medicine / Breakthrough therapy / Cancer / B-cell chronic lymphocytic leukemia / Obinutuzumab / Ofatumumab / Ibrutinib / Rituximab / Leukemia / Idelalisib / Phosphoinositide 3-kinase inhibitor

Interim statement from the BCSH CLL Guidelines Panel George A Follows1, Adrian Bloor2, Claire Dearden3, Steve Devereux4, Christopher P Fox5, Peter Hillmen6, Ben Kennedy7, Helen McCarthy8, Nilima Parry-Jones9, Piers EM Pa

Add to Reading List

Source URL: www.bcshguidelines.com

Language: English - Date: 2015-07-22 04:38:28
2

Microsoft Word - AMNOG-frühe NB-Idelalisib-Stellungnahme-AkdÄ-final

Add to Reading List

Source URL: www.akdae.de

Language: German - Date: 2016-08-19 18:04:46
    3

    Chairman’s Note Idelalisib the is first agent to target the phosphatidylinositol-3-kinase (PI3K) pathway and the second oral agent approved by the FDA, in July 2014, for treatment of relapsed/refractory chronic lymphoc

    Add to Reading List

    Source URL: gotoper-com.s3.amazonaws.com

    Language: English - Date: 2015-08-06 13:19:29
      4Specialty drugs / Biotechnology / Gilead Sciences / Breakthrough therapy / Gilead / Idelalisib / Business / Economy

      This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

      Add to Reading List

      Source URL: www.gilead.com

      Language: English - Date: 2014-07-23 23:05:41
      5Specialty drugs / Gilead Sciences / Breakthrough therapy / Gilead / Idelalisib

      This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

      Add to Reading List

      Source URL: www.gilead.com

      Language: English - Date: 2014-07-23 17:05:40
      6

      Pharmacology Update Idelalisib (Zydelig) Hien C. Tang, PharmD, James YC Shen, MD, and Betty M. Chan, PharmD, BCOP Abstract

      Add to Reading List

      Source URL: gotoper-com.s3.amazonaws.com

      Language: English - Date: 2015-08-06 13:19:37
        7Oncology / Bendamustine / Ofatumumab / Alemtuzumab / Leukemia / Rituximab / Fludarabine / Placebo / Chemotherapy / Medicine / Lymphocytic leukemia / B-cell chronic lymphocytic leukemia

        idelalisib 100mg and 150mg tablets (Zydelig®) Gilead Sciences Ltd. SMC No[removed]February 2015

        Add to Reading List

        Source URL: www.scottishmedicines.org.uk

        Language: English
        8Ketorolac / Syntex / Rituximab / Adverse effect / Colitis / Anakinra / Adverse effects of fluoroquinolones / Medicine / Health / Organofluorides

        HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYDELIG safely and effectively. See full prescribing information for ZYDELIG. ZYDELIG® (idelalisib) tablets, for or

        Add to Reading List

        Source URL: www.accessdata.fda.gov

        Language: English - Date: 2014-07-23 15:40:49
        UPDATE